Related Experiment Video
Updated: Jul 22, 2025

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
Clinical Outcomes of Transcatheter Aortic Valve Replacement With and Without Percutaneous Coronary Intervention-An
Mohammad Yassen1, Abdelmoniem Moustafa2, Barat Venkataramany3
1Department of Internal Medicine, University of Toledo Medical Center, Toledo, Ohio, United States.
Insights
Adding percutaneous coronary intervention (PCI) to transcatheter aortic valve replacement (TAVR) for severe aortic stenosis (AS) with coronary artery disease (CAD) does not improve survival. This combined approach did not reduce mortality but increased heart attack risk.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiac Surgery
Background:
- Severe aortic stenosis (AS) and obstructive coronary artery disease (CAD) often coexist in high-risk patients.
- Transcatheter aortic valve replacement (TAVR) is a standard treatment for severe AS.
- The survival benefit of combining TAVR with percutaneous coronary intervention (PCI) remains unclear.
Approach:
- A systematic literature review and meta-analysis was conducted.
- PubMed, Embase, and Cochrane Library databases were searched from inception to June 2023.
- Eleven studies with 2804 patients were analyzed to compare outcomes of TAVR alone versus TAVR+PCI.
Key Points:
- Concomitant PCI with TAVR showed no significant difference in 30-day or 6-month to 1-year all-cause mortality.
- 30-day cardiovascular mortality was not significantly reduced by the addition of PCI.
- Rates of myocardial infarction were significantly higher in the TAVR+PCI group.
Conclusions:
- Percutaneous coronary intervention (PCI) does not provide a mortality benefit when performed concurrently with transcatheter aortic valve replacement (TAVR) in patients with obstructive coronary artery disease (CAD).
- The combined TAVR and PCI strategy did not improve survival outcomes but was associated with an increased risk of myocardial infarction.
- Further research is warranted to definitively establish the role of concomitant PCI in this patient population.
Abstract:
Transcatheter aortic valve replacement (TAVR) is indicated for high-risk patients with severe degenerative aortic stenosis (AS). Given the shared risk factors and coexistence of obstructive coronary artery disease (CAD) and AS, there is inconsistent clinical data regarding potential survival benefits of paired percutaneous coronary intervention (PCI) with TAVR procedures. We performed a literature search using PubMed, Embase, and Cochrane Library from inception through June 2023 assessing the impact of concomitant PCI in patients with obstructive CAD undergoing TAVR. The primary outcomes were 30-day all-cause mortality, 30-day cardiovascular mortality, and 6 months-1 year all-cause mortality. Secondary outcomes included 30-day myocardial infarction, stroke, major bleeding complications, and acute kidney injury (AKI). A total of 11 studies involving 2804 patients were included in the final analysis. Compared to patients undergoing TAVR alone, the TAVR+PCI group showed no significant difference in 30-day all-cause mortality (RR 0.90, CI 0.66, 1.22, P = 0.49), 30-day cardiovascular mortality (RR 0.71 CI 0.44, 1.14, P = 0.16), or 6 months-1 year all-cause mortality (RR 0.94, CI 0.75, 1.18, P = 0.57). Regarding secondary outcomes, 30-day myocardial infarction was higher in the TAVR+PCI group (RR 3.09, CI 1.26, 7.57, P = 0.01), with no significant differences noted in rates of 30-day stroke (RR 1.14, CI 0.56, 2.33, P = 0.72), major bleeding/vascular complications (RR 1.11, CI 0.79, 1.56, P = 0.55), and AKI (RR 1.07, CI 0.75, 1.54, P = 0.71). Concomitant PCI does not confer any mortality benefit in patients with obstructive CAD and high-grade AS undergoing TAVR. Further trials are needed to confirm our findings.
More Related Videos
05:31Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
Published on: June 8, 2022
08:50Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
Published on: March 26, 2018
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies
Aortic Regurgitation III: Medical Management
Peripheral Artery Disease III: Interprofessional Care